TA Associates
 |
|
| Limited Partnership | |
| Industry | Private Equity |
| Founded | 1968 |
| Headquarters |
John Hancock Tower Boston, Massachusetts, United States |
|
Key people
|
Brian J. Conway, Chairman |
| Products | Growth capital, Leveraged buyouts, Recapitalizations |
| Total assets | $24 billion |
|
Number of employees
|
130+ |
| Website | www.ta.com |
TA Associates, founded in 1968, is one of the early modern-era private equity firms in the United States. The firm leads buyouts and minority recapitalizations of profitable growth companies. TA Associates has invested across a range of industries, including technology, healthcare, consumer products, financial services and business services.
TA Associates has raised $24 billion of capital since inception. Since its founding, the firm has been a lead investor and director in more than 440 companies, and been ranked among the 50 largest private equity firms (ranked 41 in 2014) globally.
The firm is headquartered in Boston, Massachusetts. As of January 1, 2015, TA had more than 130 employees, including 80 investment professionals in Boston, Menlo Park, London, Mumbai and Hong Kong.
TA Associates was founded in 1968 by Peter Brooke with the backing of his former firm, Tucker, Anthony & RL Day, an investment banking and brokerage firm. Prior to founding TA, from 1963 to 1968, Brooke had headed the corporate finance and venture capital activities of Tucker Anthony. Previously, Brooke had been responsible for expanding the private equity activities of Bessemer Securities and had founded the High Technology Lending Group of First National Bank of Boston. At the time it was founded, the firm focused primarily on making venture capital investments in earlier stage companies.
The firm expanded significantly through the 1970s growing from $5 million of capital in 1969 to $125 million by the beginning of the 1980s, making TA the largest independent venture capital firm in a 1980 ranking. Through the 1970s, the firm's investments averaged 30% to 40% annually. Among the firm's notable investments of the 1970s were Biogen, Artificial Intelligence Software, Immunogen and Digital Research
...
Wikipedia